Correlation Between Unicycive Therapeutics and Vaccinex
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Vaccinex, you can compare the effects of market volatilities on Unicycive Therapeutics and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Vaccinex.
Diversification Opportunities for Unicycive Therapeutics and Vaccinex
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Unicycive and Vaccinex is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Vaccinex go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Vaccinex
If you would invest (100.00) in Vaccinex on December 30, 2024 and sell it today you would earn a total of 100.00 from holding Vaccinex or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Unicycive Therapeutics vs. Vaccinex
Performance |
Timeline |
Unicycive Therapeutics |
Vaccinex |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Unicycive Therapeutics and Vaccinex Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Unicycive Therapeutics and Vaccinex
The main advantage of trading using opposite Unicycive Therapeutics and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |